Neurointerventional Integrated Solution Service Provider
After years of technological research and development, innovation, and accumulation, NeuroSafe Medical has developed a series of neurointerventional (Class III) medical devices with independent intellectual property rights. The company's product line covers three major areas of stroke ischemia, hemorrhage, and access, including liquid embolization systems, thrombectomy devices, suction catheters, mechanical release coil systems, distal access catheters, floating microcatheters, microcatheters, balloon guided catheters, and more.
10 Year+
Experience in Medical Device Research and Quality Management
10 Styles+
Listed and under development products
3 Styles
CE certified products
5 Styles
MDSAP certified products
30 Of them+
Registered/Admitted Countries
10 Year+
Experience in Medical Device Research and Quality Management
10 Styles+
Listed and under development products
3 Styles
CE certified products
5 Styles
MDSAP certified products
30 Of them+
Registered/Admitted Countries
PRODUCT SERIES
NeuroSafe Medical focuses on the clinical needs of doctors and patients, developing and producing innovative minimally invasive neurointerventional treatment products with broad market prospects.
Hemorrhagic cerebral stroke products
Lava liquid embolic system、Detachable coil system series products
Ischemic cerebral stroke products
Dredger revascularization device、glutton aspiration catheter series products
Intracranial vascular access products
Catheter series products
LATEST NEWS
- Neurosafe Team In KazakhstanThe NeuroSafe team was invited to visit a hospital in the Kostanay region of Kazakhstan to observe neurovascular surgery.2025-04-23
- A New Case Using Glutton And TranaviA new case for using Glutton Aspiration Catheter and Tranavi Microcatheter to open carotid artery.2025-03-28
- ALICE 2025——Surgery Performance SummaryThe patient was a 60-year-old female with complex DAVF, left sinus and sinus confluence area involved, multiple arterial blood supply and complex venous drainage, residual shunt after previous transvenous embolization. The treatment team adopted a multimodal strategy, transvenous balloon-assisted embolization combined with arterial superselective embolization, assisted by double balloon technology to control backflow.2025-03-25
- Shenping Medical participated in LINNC ASIA 2024, a grand event for neurointerventionThe 2024 LINNC Conference, a premier event in the field of neurointervention, was recently held in Bangkok, Thailand. The symposium brought together leading experts and scholars in the field of neurointervention from around the world to explore the latest advancements and future trends in neurointerventional technology. Shenping Medical made a dazzling appearance at this glittering medical event, showcasing its exceptional innovation and technological prowess in the field.2024-10-30